-- Sego Resources (SGZ.V) 週一宣布，已在不列顛哥倫比亞省的 Miner Mountain 項目啟動一項三孔、總鑽探深度 2000 公尺的鑽探計劃。 該公司表示，鑽探工作從 Cuba 礦區北部開始，旨在穿越 Quintana 2009 Titan 24 反向極化率異常區。該公司還補充說，2013 年的衝擊鑽探計畫發現了浸染狀黃鐵礦、絹雲母-綠泥石-碳酸鹽蝕變組合，並檢測到少量銅礦。 計畫在南部金礦帶區域鑽探兩個鑽孔，並在南部金礦帶北部鑽探一個深斜孔。該區域的銅金礦化以及地表零星的土壤銅金礦化可能代表斑岩型礦化，這與2009年地球物理勘探中發現的200至300米深的反演極化率異常相符。 該公司表示，計劃增設IP測線，以完善2009年的勘探範圍，並將勘探範圍向2009年勘探範圍邊緣反演極化率異常的南部和西部延伸。 「計劃在南部金礦帶東部鑽探一個淺孔，以測試地表發現的銅金礦化下方的情況。此外，在由Climax Copper Co.鑽探的64米AX鑽孔（~1.2英寸）末端，發現了厚度超過14米的、含量為幾個百分點的浸染狀黃鐵礦。」該公司補充道：「該公司被開採 該公司股票最後一次交易是在4月22日，在多倫多證券交易所創業板收在0.05美元。
Related Articles
Insider Trading
Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing
Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml
$LFST
Australia
Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set
Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.
$CLS
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.
$AMP